Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 6, 2010, Pages 863-867

  Arazi, Hernán Cohen ^a   Doiny, David G ^a   Torcivia, Ricardo Spampinato ^a   Grancelli, Hugo ^a   Waldman, Silvina V ^a   Nojek, Carlos ^a,c   Fornari, María Cecilia ^b   Badimon, Juan Jose ^d  

^a FLENI   (Argentina)

^b Laboratorio de Análisis Clínicos Fornari Bioalpha SA   (Argentina)

^c Cardiology Section   (Argentina)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aggregation; Cardiopulmonary bypass; Complications; IL6; Inflammatory; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; INTERLEUKIN 6; THROMBOMODULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG RESPONSE; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HEART SURGERY; HUMAN; MALE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOCYTE METABOLISM; THROMBOCYTE TURNOVER; THROMBOSIS;

AGED; ASPIRIN; BIOLOGICAL MARKERS; BLOOD PLATELETS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PROSPECTIVE STUDIES; THROMBOMODULIN; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954629651     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.229542     Document Type: Article

References (15)

1. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-1317.
2. Zimmermann N, Gams E, Hohfeld T. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Eur J Cardiothorac Surg 2008;34:93-108.
3. Stein PD, Schunemann HJ, Dalen JE, Gutterman D. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:600-608.
4. Zimmermann N, Kienzle P, Weber AA, Winter J, Gams E, Schrör K, Hohlfeld T. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2001;121:982-984.
5. Zimmermann N, Kurt M, Winter J, Gams E, Wenzel F, Hohfeld T. Detection and duration of aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2008;135:947-948.
6. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006;367:606-617.
7. Schwartz KA. Aspirin resistance: a review of diagnostic methodology, mechanisms, and clinical utility. Adv Clin Chem 2006;42:81-110.
8. Kaser A, Brandacher G, Steur W, Kaser S, Offner FA, Zoller H, Theurl I, Widder W, Moinar C, Ludwiczek O, Atkins MB, Mier J, Tilg H. Interleukin 6 stimulates thrombopoiesis through thrombopoietin: role of inflammatory thrombocytosis. Blood 2001;98:2720-2725.
9. The ACCP/SCCM American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
10. Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams K, Schrör K, Hohlfeld T. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 2003;108:542-547.
11. Zimmerman N, Kurt M, Wenk A, Winter J, Gams E, Hohfeld T. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Eur J Cardiothorac Surg 2005;27:606.
12. Perneby C, Wallen H, Rooney C, Fitzgerald D, Hjemdahl P. Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost 2006;95:652-658.
13. Guthikonda S, Lev EI, Patel R, Delao T, Bergeron J, Dong F, Kleinman NS. Reticulated platelets and inhibited COX-1 and COX-2 decrease the platelet effect of aspirin. J Thromb Haemost 2007;5:490-496.
14. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:S715-S720.
15. Lin SH, Wang YM, Chyuan H, Lee KY, Huang CD, Liu CY, Wang CH, Kuo HP. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis. Crit Care Med 2008;36:683-689.